電子ドラッグデリバリーシステムの世界市場:種類別(電子ウェアラブル注入ポンプ、自動注射器、注射ペン、電子吸入器)、疾患別(糖尿病、多発性硬化症、心血管疾患、喘息、COPD)

◆英語タイトル:Global Electronic Drug Delivery Systems Market Size study, by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), by Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) and Regional Forecasts 2019-2026
◆商品コード:BZW20JN002
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2019年12月31日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD3,950 ⇒換算¥450,300見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD5,550 ⇒換算¥632,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは電子ドラッグデリバリーシステム市場について、エグゼクティブサマリー、定義および範囲、市場動向、産業分析、タイプ別(電子ウェアラブル注入ポンプ、自動注射器、注射ペン、電子吸入器)分析、疾患別(糖尿病、多発性硬化症、心血管疾患、喘息、COPD)分析、地域別分析、競争状況、調査プロセスなどを総合的、多面的に調査・分析しました。
・エグゼクティブサマリー
・定義および範囲
・市場動向
・産業分析
・電子ドラッグデリバリーシステムの世界市場:種類別(電子ウェアラブル注入ポンプ、自動注射器、注射ペン、電子吸入器)
・電子ドラッグデリバリーシステムの世界市場:疾患別(糖尿病、多発性硬化症、心血管疾患、喘息、COPD)
・電子ドラッグデリバリーシステムの世界市場:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Electronic Drug Delivery Systems Market is valued approximately USD 7.2 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 8.7% over the forecast period 2019-2026. Drug delivery includes formulations, technologies, methods and systems for transferring an active pharmaceutical ingredient into the body. Electronic drug delivery systems are an advancement in the field which provides portable, interactive, wirelessly connected delivery systems and support patient administered therapy. The high prevalence of target diseases, the favorable reimbursement scenario in major markets, and advancements in technologies and designs of electronic drug delivery systems has increased the adoption of Electronic Drug Delivery Systems across the globe. However, the operation and functionality issues associated with the electronic devices will act as a restriction to the electronic drug delivery system market.

The regional analysis of global Electronic Drug Delivery Systems market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising prevalence of target diseases, the favorable reimbursement scenario, and approvals, and launches of innovative electronic drug delivery systems in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as increasing population along with increasing government expenditure on public health and research and development would create lucrative growth prospects for the Electronic Drug Delivery Systems market across Asia-Pacific region.

Major market player included in this report are:
Merck Group (Germany)
Insulet Corporation (US)
Bayer AG (Germany)
Medtronic PLC (Ireland)
Novo Nordisk (Denmark)
United Therapeutics Corporation (US)
Astrazeneca (UK)
Tandem Diabetes Care (US)
Amgen (US)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Electronic Wearable Infusion Pumps
Electronic Autoinjectors
Electronic Injection Pens
Electronic Inhalers

By Indication:
Diabetes
Multiple Sclerosis
Cardiovascular Disease
Asthma & COPD
Other Indications (growth hormone therapy, primary immunodeficiency disease, thalassemia, and Parkinson’s disease)

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Electronic Drug Delivery Systems Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investor

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1. Electronic Drug Delivery Systems Market, by Type, 2016-2026 (USD Billion)
1.3.2. Electronic Drug Delivery Systems Market, by Indication, 2016-2026 (USD Billion)
1.3.3. Electronic Drug Delivery Systems Market, by Region, 2016-2026 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Electronic Drug Delivery Systems Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Electronic Drug Delivery Systems Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Electronic Drug Delivery Systems Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria (On Demand)
4.4. Regulatory Framework (On Demand)
4.5. Investment Vs Adoption Scenario (On Demand)
4.6. Analyst Recommendation & Conclusion
Chapter 5. Global Electronic Drug Delivery Systems Market, by Type
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Electronic Drug Delivery Systems Market, Sub Segment Analysis
5.3.1. Electronic Wearable Infusion Pumps
5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.2. Electronic Autoinjectors
5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.3. Electronic Injection Pens
5.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.4. Electronic Inhalers
5.3.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6. Global Electronic Drug Delivery Systems Market, by Indication
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Electronic Drug Delivery Systems Market, Sub Segment Analysis
6.3.1. Diabetes
6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.2. Multiple Sclerosis
6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.3. Cardiovascular Disease
6.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.4. Asthma & COPD
6.3.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.5. Other Indications
6.3.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 7. Global Electronic Drug Delivery Systems Market, by Regional Analysis
7.1. Electronic Drug Delivery Systems Market, Regional Market Snapshot (2016-2026)
7.2. North America Electronic Drug Delivery Systems Market Snapshot
7.2.1. U.S.
7.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2. Canada
7.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3. Europe Electronic Drug Delivery Systems Market Snapshot
7.3.1. U.K.
7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2. Germany
7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3. Rest of Europe
7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4. Asia Electronic Drug Delivery Systems Market Snapshot
7.4.1. China
7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2. India
7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3. Japan
7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4. Rest of Asia Pacific
7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5. Latin America Electronic Drug Delivery Systems Market Snapshot
7.5.1. Brazil
7.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.2. Mexico
7.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6. Rest of The World
7.6.1. Middle East and Africa
7.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.3. Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 8. Competitive Intelligence
8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Merck Group (Germany)
8.3.1.1. Overview
8.3.1.2. Financial (Subject to Data Availability)
8.3.1.3. Product Summary
8.3.1.4. Recent Developments
8.3.2. Insulet Corporation (US)
8.3.3. Bayer AG (Germany)
8.3.4. Medtronic PLC (Ireland)
8.3.5. Novo Nordisk (Denmark)
8.3.6. United Therapeutics Corporation (US)
8.3.7. AstraZeneca (UK)
8.3.8. Tandem Diabetes Care (US)
8.3.9. Amgen (US)
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.1.6. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET
TABLE 3. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY COMPOSITION 2016-2026 (USD BILLION)
TABLE 8. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)
TABLE 9. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 10. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 22. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 25. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 27. U.S. ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 28. U.S. ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 29. U.S. ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. CANADA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 31. CANADA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 32. CANADA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. UK ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 34. UK ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 35. UK ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. GERMANY ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 37. GERMANY ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 38. GERMANY ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. ROE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 40. ROE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 41. ROE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. CHINA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 43. CHINA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 44. CHINA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. INDIA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 46. INDIA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 47. INDIA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. JAPAN ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 49. JAPAN ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50. JAPAN ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. ROAPAC ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 52. ROAPAC ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 53. ROAPAC ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 55. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. MEXICO ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 58. MEXICO ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 59. MEXICO ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 60. ROLA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 61. ROLA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 62. ROLA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 63. ROW ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 64. ROW ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 65. ROW ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[電子ドラッグデリバリーシステムの世界市場:種類別(電子ウェアラブル注入ポンプ、自動注射器、注射ペン、電子吸入器)、疾患別(糖尿病、多発性硬化症、心血管疾患、喘息、COPD)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆